Fetal programming of polycystic ovary syndrome

doi:10.4239/wjd.v6.i7.936

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8674)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

660

WORD

511

HTML

4429

Figures (1-1)

398

Tables (1-1)

273

Sum=6271

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

992

Download

1411

Sum=2403

Jul 10, 2015 (publication date) through Dec 30, 2024

Times Cited of This Article

Times Cited (38)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Jul 10, 2015; 6(7): 936-942
Published online Jul 10, 2015. doi: 10.4239/wjd.v6.i7.936

Open in New Tab Full Size Figure Download Figure

Figure 1 Possible effects of prenatal excess androgen on the fetus. PCOS: Polycystic ovary syndrome; LH: Luteinizing hormone; IUGT: Intrauterine growth restriction.

Citation: Gur EB, Karadeniz M, Turan GA. Fetal programming of polycystic ovary syndrome. World J Diabetes 2015; 6(7): 936-942
URL: https://www.wjgnet.com/1948-9358/full/v6/i7/936.htm
DOI: https://dx.doi.org/10.4239/wjd.v6.i7.936